EcoDrugPlus

Coagulation Factor Iii, Tissue Factor

Ensembl ID : ENSCSEG00000009377
Gene Symbol: F3
3 Cross references
199 Possible Orthologues:

Coagulation Factor Vii, Like

Ensembl ID : ENSCSEG00000008562
Gene Symbol: F7L
1 Cross references
203 Possible Orthologues:

Coagulation Factor X

Ensembl ID : ENSCSEG00000014571
Gene Symbol: F10
3 Cross references
246 Possible Orthologues:

Coiled-Coil Domain Containing 6

Ensembl ID : ENSCSEG00000002947
Gene Symbol: CCDC6
3 Cross references
208 Possible Orthologues:

Collagenase 3-Like

Ensembl ID : ENSCSEG00000012522
Gene Symbol: LOC103394801
2 Cross references
275 Possible Orthologues:

Collagenase 3-Like

Ensembl ID : ENSCSEG00000012534
Gene Symbol: LOC103394800
2 Cross references
264 Possible Orthologues:

Colony Stimulating Factor 1 Receptor, A

Ensembl ID : ENSCSEG00000010627
Gene Symbol: CSF1RA
1 Cross references
207 Possible Orthologues:

Complement C5

Ensembl ID : ENSCSEG00000008818
Gene Symbol: LOC103397976
2 Cross references
216 Possible Orthologues:

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSCSEG00000009657
Gene Symbol: CRHR1
3 Cross references
209 Possible Orthologues:

Cyclin D1

Ensembl ID : ENSCSEG00000001379
Gene Symbol: CCND1
4 Cross references
205 Possible Orthologues:

Cyclin Dependent Kinase 1

Ensembl ID : ENSCSEG00000001655
Gene Symbol: CDK1
3 Cross references
246 Possible Orthologues:

Cyclin Dependent Kinase 2

Ensembl ID : ENSCSEG00000004193
Gene Symbol: CDK2
3 Cross references
203 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).